Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM176195 (US10047103, 228 | US9688695, 228) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.180 | n/a | n/a | n/a | 25 |
BRISTOL-MYERS SQUIBB COMPANY US Patent | Assay Description Briefly, HEK293 EBNA PAR4 clone 20664.1J cells were plated 24 hrs. prior to experiment in 384 well, Poly-D-Lysine coated, black, clear bottom plates ... | US Patent US9688695 (2017) BindingDB Entry DOI: 10.7270/Q28K777N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM176195 (US10047103, 228 | US9688695, 228) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.180 | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite de Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US10047103 (2018) BindingDB Entry DOI: 10.7270/Q2QF8VWN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM176017 (US10047103, 50 | US9688695, 50) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.210 | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite de Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US10047103 (2018) BindingDB Entry DOI: 10.7270/Q2QF8VWN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM176017 (US10047103, 50 | US9688695, 50) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.210 | n/a | n/a | n/a | 25 |
BRISTOL-MYERS SQUIBB COMPANY US Patent | Assay Description Briefly, HEK293 EBNA PAR4 clone 20664.1J cells were plated 24 hrs. prior to experiment in 384 well, Poly-D-Lysine coated, black, clear bottom plates ... | US Patent US9688695 (2017) BindingDB Entry DOI: 10.7270/Q28K777N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM176036 (US10047103, 69 | US9688695, 69) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.230 | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite de Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US10047103 (2018) BindingDB Entry DOI: 10.7270/Q2QF8VWN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM176036 (US10047103, 69 | US9688695, 69) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.230 | n/a | n/a | n/a | 25 |
BRISTOL-MYERS SQUIBB COMPANY US Patent | Assay Description Briefly, HEK293 EBNA PAR4 clone 20664.1J cells were plated 24 hrs. prior to experiment in 384 well, Poly-D-Lysine coated, black, clear bottom plates ... | US Patent US9688695 (2017) BindingDB Entry DOI: 10.7270/Q28K777N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM176023 (US10047103, 56 | US9688695, 56) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.240 | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite de Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US10047103 (2018) BindingDB Entry DOI: 10.7270/Q2QF8VWN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM176023 (US10047103, 56 | US9688695, 56) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.240 | n/a | n/a | n/a | 25 |
BRISTOL-MYERS SQUIBB COMPANY US Patent | Assay Description Briefly, HEK293 EBNA PAR4 clone 20664.1J cells were plated 24 hrs. prior to experiment in 384 well, Poly-D-Lysine coated, black, clear bottom plates ... | US Patent US9688695 (2017) BindingDB Entry DOI: 10.7270/Q28K777N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM176067 (US10047103, 100 | US9688695, 100) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.25 | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite de Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US10047103 (2018) BindingDB Entry DOI: 10.7270/Q2QF8VWN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM176067 (US10047103, 100 | US9688695, 100) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.25 | n/a | n/a | n/a | 25 |
BRISTOL-MYERS SQUIBB COMPANY US Patent | Assay Description Briefly, HEK293 EBNA PAR4 clone 20664.1J cells were plated 24 hrs. prior to experiment in 384 well, Poly-D-Lysine coated, black, clear bottom plates ... | US Patent US9688695 (2017) BindingDB Entry DOI: 10.7270/Q28K777N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM176134 (US10047103, 167 | US9688695, 167) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.260 | n/a | n/a | n/a | 25 |
BRISTOL-MYERS SQUIBB COMPANY US Patent | Assay Description Briefly, HEK293 EBNA PAR4 clone 20664.1J cells were plated 24 hrs. prior to experiment in 384 well, Poly-D-Lysine coated, black, clear bottom plates ... | US Patent US9688695 (2017) BindingDB Entry DOI: 10.7270/Q28K777N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM176111 (US10047103, 144 | US9688695, 144) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.260 | n/a | n/a | n/a | 25 |
BRISTOL-MYERS SQUIBB COMPANY US Patent | Assay Description Briefly, HEK293 EBNA PAR4 clone 20664.1J cells were plated 24 hrs. prior to experiment in 384 well, Poly-D-Lysine coated, black, clear bottom plates ... | US Patent US9688695 (2017) BindingDB Entry DOI: 10.7270/Q28K777N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM176007 (US10047103, 40 | US9688695, 40) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.260 | n/a | n/a | n/a | 25 |
BRISTOL-MYERS SQUIBB COMPANY US Patent | Assay Description Briefly, HEK293 EBNA PAR4 clone 20664.1J cells were plated 24 hrs. prior to experiment in 384 well, Poly-D-Lysine coated, black, clear bottom plates ... | US Patent US9688695 (2017) BindingDB Entry DOI: 10.7270/Q28K777N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM176018 (US10047103, 51 | US9688695, 51) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.260 | n/a | n/a | n/a | 25 |
BRISTOL-MYERS SQUIBB COMPANY US Patent | Assay Description Briefly, HEK293 EBNA PAR4 clone 20664.1J cells were plated 24 hrs. prior to experiment in 384 well, Poly-D-Lysine coated, black, clear bottom plates ... | US Patent US9688695 (2017) BindingDB Entry DOI: 10.7270/Q28K777N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM176039 (US10047103, 72 | US9688695, 72) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.260 | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite de Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US10047103 (2018) BindingDB Entry DOI: 10.7270/Q2QF8VWN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM176111 (US10047103, 144 | US9688695, 144) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.260 | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite de Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US10047103 (2018) BindingDB Entry DOI: 10.7270/Q2QF8VWN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM176134 (US10047103, 167 | US9688695, 167) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.260 | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite de Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US10047103 (2018) BindingDB Entry DOI: 10.7270/Q2QF8VWN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM176007 (US10047103, 40 | US9688695, 40) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.260 | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite de Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US10047103 (2018) BindingDB Entry DOI: 10.7270/Q2QF8VWN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM176018 (US10047103, 51 | US9688695, 51) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.260 | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite de Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US10047103 (2018) BindingDB Entry DOI: 10.7270/Q2QF8VWN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM176039 (US10047103, 72 | US9688695, 72) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.260 | n/a | n/a | n/a | 25 |
BRISTOL-MYERS SQUIBB COMPANY US Patent | Assay Description Briefly, HEK293 EBNA PAR4 clone 20664.1J cells were plated 24 hrs. prior to experiment in 384 well, Poly-D-Lysine coated, black, clear bottom plates ... | US Patent US9688695 (2017) BindingDB Entry DOI: 10.7270/Q28K777N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM176259 (US10047103, 292 | US9688695, 292) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.270 | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite de Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US10047103 (2018) BindingDB Entry DOI: 10.7270/Q2QF8VWN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM176138 (US10047103, 171 | US9688695, 171) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.270 | n/a | n/a | n/a | 25 |
BRISTOL-MYERS SQUIBB COMPANY US Patent | Assay Description Briefly, HEK293 EBNA PAR4 clone 20664.1J cells were plated 24 hrs. prior to experiment in 384 well, Poly-D-Lysine coated, black, clear bottom plates ... | US Patent US9688695 (2017) BindingDB Entry DOI: 10.7270/Q28K777N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM176259 (US10047103, 292 | US9688695, 292) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.270 | n/a | n/a | n/a | 25 |
BRISTOL-MYERS SQUIBB COMPANY US Patent | Assay Description Briefly, HEK293 EBNA PAR4 clone 20664.1J cells were plated 24 hrs. prior to experiment in 384 well, Poly-D-Lysine coated, black, clear bottom plates ... | US Patent US9688695 (2017) BindingDB Entry DOI: 10.7270/Q28K777N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM176058 (US10047103, 91 | US9688695, 91) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.270 | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite de Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US10047103 (2018) BindingDB Entry DOI: 10.7270/Q2QF8VWN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM176088 (US10047103, 121 | US9688695, 121) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.270 | n/a | n/a | n/a | 25 |
BRISTOL-MYERS SQUIBB COMPANY US Patent | Assay Description Briefly, HEK293 EBNA PAR4 clone 20664.1J cells were plated 24 hrs. prior to experiment in 384 well, Poly-D-Lysine coated, black, clear bottom plates ... | US Patent US9688695 (2017) BindingDB Entry DOI: 10.7270/Q28K777N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM176088 (US10047103, 121 | US9688695, 121) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.270 | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite de Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US10047103 (2018) BindingDB Entry DOI: 10.7270/Q2QF8VWN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM176138 (US10047103, 171 | US9688695, 171) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.270 | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite de Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US10047103 (2018) BindingDB Entry DOI: 10.7270/Q2QF8VWN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM176058 (US10047103, 91 | US9688695, 91) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.270 | n/a | n/a | n/a | 25 |
BRISTOL-MYERS SQUIBB COMPANY US Patent | Assay Description Briefly, HEK293 EBNA PAR4 clone 20664.1J cells were plated 24 hrs. prior to experiment in 384 well, Poly-D-Lysine coated, black, clear bottom plates ... | US Patent US9688695 (2017) BindingDB Entry DOI: 10.7270/Q28K777N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM176135 (US10047103, 168 | US9688695, 168) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.280 | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite de Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US10047103 (2018) BindingDB Entry DOI: 10.7270/Q2QF8VWN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM176135 (US10047103, 168 | US9688695, 168) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.280 | n/a | n/a | n/a | 25 |
BRISTOL-MYERS SQUIBB COMPANY US Patent | Assay Description Briefly, HEK293 EBNA PAR4 clone 20664.1J cells were plated 24 hrs. prior to experiment in 384 well, Poly-D-Lysine coated, black, clear bottom plates ... | US Patent US9688695 (2017) BindingDB Entry DOI: 10.7270/Q28K777N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM176179 (US10047103, 212 | US9688695, 212) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.290 | n/a | n/a | n/a | 25 |
BRISTOL-MYERS SQUIBB COMPANY US Patent | Assay Description Briefly, HEK293 EBNA PAR4 clone 20664.1J cells were plated 24 hrs. prior to experiment in 384 well, Poly-D-Lysine coated, black, clear bottom plates ... | US Patent US9688695 (2017) BindingDB Entry DOI: 10.7270/Q28K777N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM176091 (US10047103, 124 | US9688695, 124) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.290 | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite de Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US10047103 (2018) BindingDB Entry DOI: 10.7270/Q2QF8VWN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM176179 (US10047103, 212 | US9688695, 212) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.290 | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite de Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US10047103 (2018) BindingDB Entry DOI: 10.7270/Q2QF8VWN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM176091 (US10047103, 124 | US9688695, 124) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.290 | n/a | n/a | n/a | 25 |
BRISTOL-MYERS SQUIBB COMPANY US Patent | Assay Description Briefly, HEK293 EBNA PAR4 clone 20664.1J cells were plated 24 hrs. prior to experiment in 384 well, Poly-D-Lysine coated, black, clear bottom plates ... | US Patent US9688695 (2017) BindingDB Entry DOI: 10.7270/Q28K777N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM176149 (US10047103, 182 | US9688695, 182) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.300 | n/a | n/a | n/a | 25 |
BRISTOL-MYERS SQUIBB COMPANY US Patent | Assay Description Briefly, HEK293 EBNA PAR4 clone 20664.1J cells were plated 24 hrs. prior to experiment in 384 well, Poly-D-Lysine coated, black, clear bottom plates ... | US Patent US9688695 (2017) BindingDB Entry DOI: 10.7270/Q28K777N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM176053 (US10047103, 86 | US9688695, 86) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.300 | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite de Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US10047103 (2018) BindingDB Entry DOI: 10.7270/Q2QF8VWN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM176149 (US10047103, 182 | US9688695, 182) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.300 | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite de Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US10047103 (2018) BindingDB Entry DOI: 10.7270/Q2QF8VWN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM176053 (US10047103, 86 | US9688695, 86) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.300 | n/a | n/a | n/a | 25 |
BRISTOL-MYERS SQUIBB COMPANY US Patent | Assay Description Briefly, HEK293 EBNA PAR4 clone 20664.1J cells were plated 24 hrs. prior to experiment in 384 well, Poly-D-Lysine coated, black, clear bottom plates ... | US Patent US9688695 (2017) BindingDB Entry DOI: 10.7270/Q28K777N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM176194 (US10047103, 227 | US9688695, 227) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.310 | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite de Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US10047103 (2018) BindingDB Entry DOI: 10.7270/Q2QF8VWN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM176194 (US10047103, 227 | US9688695, 227) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.310 | n/a | n/a | n/a | 25 |
BRISTOL-MYERS SQUIBB COMPANY US Patent | Assay Description Briefly, HEK293 EBNA PAR4 clone 20664.1J cells were plated 24 hrs. prior to experiment in 384 well, Poly-D-Lysine coated, black, clear bottom plates ... | US Patent US9688695 (2017) BindingDB Entry DOI: 10.7270/Q28K777N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM176070 (US10047103, 103 | US9688695, 103) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.310 | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite de Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US10047103 (2018) BindingDB Entry DOI: 10.7270/Q2QF8VWN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM176109 (US10047103, 142 | US9688695, 142) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.310 | n/a | n/a | n/a | 25 |
BRISTOL-MYERS SQUIBB COMPANY US Patent | Assay Description Briefly, HEK293 EBNA PAR4 clone 20664.1J cells were plated 24 hrs. prior to experiment in 384 well, Poly-D-Lysine coated, black, clear bottom plates ... | US Patent US9688695 (2017) BindingDB Entry DOI: 10.7270/Q28K777N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM176109 (US10047103, 142 | US9688695, 142) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.310 | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite de Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US10047103 (2018) BindingDB Entry DOI: 10.7270/Q2QF8VWN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM176070 (US10047103, 103 | US9688695, 103) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.310 | n/a | n/a | n/a | 25 |
BRISTOL-MYERS SQUIBB COMPANY US Patent | Assay Description Briefly, HEK293 EBNA PAR4 clone 20664.1J cells were plated 24 hrs. prior to experiment in 384 well, Poly-D-Lysine coated, black, clear bottom plates ... | US Patent US9688695 (2017) BindingDB Entry DOI: 10.7270/Q28K777N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM175970 (US10047103, 3 | US9605024, Example 3 | US9688695, ...) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.320 | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US9605024 (2017) BindingDB Entry DOI: 10.7270/Q25D8TWX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM176072 (US10047103, 105 | US9688695, 105) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.320 | n/a | n/a | n/a | 25 |
BRISTOL-MYERS SQUIBB COMPANY US Patent | Assay Description Briefly, HEK293 EBNA PAR4 clone 20664.1J cells were plated 24 hrs. prior to experiment in 384 well, Poly-D-Lysine coated, black, clear bottom plates ... | US Patent US9688695 (2017) BindingDB Entry DOI: 10.7270/Q28K777N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM176083 (US10047103, 116 | US9688695, 116) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.320 | n/a | n/a | n/a | 25 |
BRISTOL-MYERS SQUIBB COMPANY US Patent | Assay Description Briefly, HEK293 EBNA PAR4 clone 20664.1J cells were plated 24 hrs. prior to experiment in 384 well, Poly-D-Lysine coated, black, clear bottom plates ... | US Patent US9688695 (2017) BindingDB Entry DOI: 10.7270/Q28K777N | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM175970 (US10047103, 3 | US9605024, Example 3 | US9688695, ...) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.320 | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite de Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US10047103 (2018) BindingDB Entry DOI: 10.7270/Q2QF8VWN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM176072 (US10047103, 105 | US9688695, 105) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.320 | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite de Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US10047103 (2018) BindingDB Entry DOI: 10.7270/Q2QF8VWN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM175995 (US10047103, 75 | US9605024, Example 28 | US9688695...) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.320 | n/a | n/a | n/a | 25 |
BRISTOL-MYERS SQUIBB COMPANY US Patent | Assay Description Briefly, HEK293 EBNA PAR4 clone 20664.1J cells were plated 24 hrs. prior to experiment in 384 well, Poly-D-Lysine coated, black, clear bottom plates ... | US Patent US9688695 (2017) BindingDB Entry DOI: 10.7270/Q28K777N | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 863 total ) | Next | Last >> |